SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-18-011581
Filing Date
2018-09-20
Accepted
2018-09-20 16:24:17
Documents
2
Period of Report
2018-09-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 14048
2 POA dfpoatemplate.txt EX-24.TXT 3450
  Complete submission text file 0001179110-18-011581.txt   18797
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
IMMUNOGEN INC (Issuer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IMMUNOGEN, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
FOSTER DAVID G (Reporting) CIK: 0001177854 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17999 | Film No.: 181079694